IBS Interim Report January - June 2011
25 août 2011 05h57 HE
|
IBS AB
IBS Interim Report January - June 2011
JANUARY-JUNE 2011
· Total revenue decreased to SEK 558 m (664), with professional
services revenue down to SEK 313 m (405) and hardware and other...
IBS ansökan om avnotering från First North har bifallits
18 août 2011 04h42 HE
|
IBS AB
IBS ansökan om avnotering från First North har bifallits
First North har bifallit IBS AB:s ansökan om avnotering, med sista
handelsdag den 31 augusti 2011.
Styrelsen i IBS AB beslutade vid extra...
IBS applies for delisting from First North
19 juil. 2011 04h45 HE
|
IBS AB
IBS applies for delisting from First North
The board of directors in IBS AB (publ) (“IBS”) have received a demand
from STG IBS Holding S.a.r.l. to initiate the compulsory acquisition
procedure under...
Symphony Technology Group holds 94.91 percent of the shares in IBS
29 juin 2011 07h00 HE
|
IBS AB
Symphony Technology Group holds 94.91 percent of the shares in IBS
Symphony Technology Group's (“STG”) offer to the shareholders of IBS AB
(publ) (“IBS”) has been accepted by shareholders...
Symphony Technology Group innehar 94,91 procent av aktierna i IBS
29 juin 2011 07h00 HE
|
IBS AB
Symphony Technology Group innehar 94,91 procent av aktierna i IBS
Symphony Technology Groups (”STG”) erbjudande till aktieägarna i IBS AB
(publ) (”IBS”) har accepterats av ägare till cirka 94,91...
IBS announces the formation of the CEO office
22 juin 2011 08h19 HE
|
IBS AB
IBS announces the formation of the CEO office
The board of directors at IBS AB has today appointed Christian Paulsson
as new acting CEO and COO. Mr. Paulsson will assume the new position on
June...
Annual General Meeting in IBS AB
22 juin 2011 07h38 HE
|
IBS AB
Annual General Meeting in IBS AB
At the annual general meeting in IBS AB today the following was
resolved.
· The meeting elected Dr. Pallab Chatterjee, Arvid Carlsen, Rene
Svendsen‑Tune and JT...
IBS Pharma standard implemented as a comprehensive solution within six months
20 juin 2011 03h30 HE
|
IBS AB
IBS Pharma standard implemented as a comprehensive solution within six
months
Pharmaceutical wholesaler Gesine introduces IBS industry solution step
by step ‑ Smooth live start thanks to...
Shareholder proposals for Board of Directors in IBS AB (publ) etc. in relation to the annual general meeting to be held on 22 June 2011
17 juin 2011 11h36 HE
|
IBS AB
Shareholder proposals for Board of Directors in IBS AB (publ) etc. in
relation to the annual general meeting to be held on 22 June 2011
Resolution on the number of board members, resolution on fees...
SYMPHONY TECHNOLOGY GROUP DECLARES ITS OFFER FOR IBS UNCONDITIONAL
01 juin 2011 01h30 HE
|
IBS AB
SYMPHONY TECHNOLOGY GROUP DECLARES ITS OFFER FOR IBS UNCONDITIONAL
The offer referred to in this press release is not being made, and this
press release may not be distributed, directly or...